Study: Asthma drug does not speed COVID-19 recovery

Russell Rothman, MD, MPP (Internal Medicine and Public Health), is first author of a study recently published in JAMA Network Open that found montelukast, a drug commonly prescribed to prevent and treat asthma and exercise-induced bronchoconstriction, does not speed recovery from symptoms of mild to moderate COVID-19.